<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20190208//EN"
       "JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.4" xml:lang="en">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">Russian veterinary journal</journal-id>
   <journal-title-group>
    <journal-title xml:lang="en">Russian veterinary journal</journal-title>
    <trans-title-group xml:lang="ru">
     <trans-title>Российский ветеринарный журнал</trans-title>
    </trans-title-group>
   </journal-title-group>
   <issn publication-format="print">2500-4379</issn>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="publisher-id">67180</article-id>
   <article-categories>
    <subj-group subj-group-type="toc-heading" xml:lang="ru">
     <subject>ДЕРМАТОЛОГИЯ</subject>
    </subj-group>
    <subj-group subj-group-type="toc-heading" xml:lang="en">
     <subject>DERMATOLOGY</subject>
    </subj-group>
    <subj-group>
     <subject>ДЕРМАТОЛОГИЯ</subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title xml:lang="en">Evaluation of clonality from multiple anatomic sites in canine epitheliotropic T cell lymphoma</article-title>
    <trans-title-group xml:lang="ru">
     <trans-title>Оценка клональности эпителиотропной Т-клеточной лимфомы собак разной анатомической локализации</trans-title>
    </trans-title-group>
   </title-group>
   <contrib-group content-type="authors">
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Китинг</surname>
       <given-names>М. Келли </given-names>
      </name>
      <name xml:lang="en">
       <surname>Keating</surname>
       <given-names>M. Kelly </given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Розенкранц</surname>
       <given-names>Вейн С. </given-names>
      </name>
      <name xml:lang="en">
       <surname>Rosenkrantz</surname>
       <given-names>Wayne S. </given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-2"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Келлер</surname>
       <given-names>Стефан М. </given-names>
      </name>
      <name xml:lang="en">
       <surname>Keller</surname>
       <given-names>Stefan M. </given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-3"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Моор</surname>
       <given-names>Питер Ф. </given-names>
      </name>
      <name xml:lang="en">
       <surname>Moore</surname>
       <given-names>Peter F. </given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-4"/>
    </contrib>
   </contrib-group>
   <aff-alternatives id="aff-1">
    <aff>
     <institution xml:lang="ru">Ветеринарная клиника</institution>
     <city>Тастин</city>
     <country>США</country>
    </aff>
    <aff>
     <institution xml:lang="en">Veterinary clinic</institution>
     <city>Tustin</city>
     <country>United States of America</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-2">
    <aff>
     <institution xml:lang="ru">Ветеринарная клиника</institution>
     <city>Тастин</city>
     <country>США</country>
    </aff>
    <aff>
     <institution xml:lang="en">Veterinary clinic</institution>
     <city>Tustin</city>
     <country>United States of America</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-3">
    <aff>
     <institution xml:lang="ru">Университет Калифорнии-Дэвис</institution>
     <city>Дэвис</city>
     <country>США</country>
    </aff>
    <aff>
     <institution xml:lang="en">University of California-Davis</institution>
     <city>Davis</city>
     <country>United States of America</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-4">
    <aff>
     <institution xml:lang="ru">Университет Калифорнии-Дэвис</institution>
     <city>Дэвис</city>
     <country>США</country>
    </aff>
    <aff>
     <institution xml:lang="en">University of California-Davis</institution>
     <city>Davis</city>
     <country>United States of America</country>
    </aff>
   </aff-alternatives>
   <pub-date publication-format="print" date-type="pub" iso-8601-date="2023-07-07T16:25:30+03:00">
    <day>07</day>
    <month>07</month>
    <year>2023</year>
   </pub-date>
   <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2023-07-07T16:25:30+03:00">
    <day>07</day>
    <month>07</month>
    <year>2023</year>
   </pub-date>
   <volume>2023</volume>
   <issue>2</issue>
   <fpage>32</fpage>
   <lpage>41</lpage>
   <history>
    <date date-type="received" iso-8601-date="2023-07-05T00:00:00+03:00">
     <day>05</day>
     <month>07</month>
     <year>2023</year>
    </date>
   </history>
   <self-uri xlink:href="https://logospress.editorum.ru/en/nauka/article/67180/view">https://logospress.editorum.ru/en/nauka/article/67180/view</self-uri>
   <abstract xml:lang="ru">
    <p>Предпосылки. Полагают, что эпителиотропная кожная Т-клеточная лимфома собак (эКТКЛ) представляет собой заболевание, гомологичное фунгоидной гранулеме (ФГ) у человека. При ФГ у людей опухолевые клетки фенотипически соответствуют резидентным эффекторным Т-клеткам памяти, популяции, сохраняющейся в тканях длительное время без циркуляции. У собак с эКТКЛ часто появляются очаги в разных местах, что вызывает вопрос, происходит ли новообразование из одной субпопуляции Т-клеток или нет.&#13;
Цели. Описать перестройки гена антигенного рецептора лимфоцитов из кожи и крови собак с эКТКЛ, чтобы установить, идентичны ли клоны опухоли.&#13;
Животные. 14 собак с эКТКЛ.&#13;
Материалы и методы. Гистологическое и иммуногистохимическое исследование, ПЦР для обнаружения перестройки антигенного рецептора (PARR) Т-клеточного рецептора гамма (TRG) различных биоптатов кожи и крови.&#13;
Результаты. Все биоптаты кожи содержали неопластические лимфоциты, содержащие кластер дифференциации (CD)3. У отдельных собак все биоптаты кожи показали идентичные профили клональности TRG, что дает основания предполагать присутствие одного опухолевого клона во всех очагах. В крови соответствующий клон обнаружен у 6 из 14 собак, уникальный клон выявлен у 9 из 14 собак, и у 2 из 14 не было обнаружено клона.&#13;
Выводы. Эти данные показывают, что очаги эКТКЛ собак в нескольких локализациях содержат один клон опухоли, неопластические лимфоциты не остаются неподвижно в коже, а могут циркулировать в крови, в коже и крови можно обнаружить различающиеся клоны, и циркулирующие неопластические клетки не обязательно сопровождаются лимфоцитозом.</p>
   </abstract>
   <trans-abstract xml:lang="en">
    <p>Background. Canine epitheliotropic cutaneous T-cell lymphoma (eCTCL) is thought to represent a disease homologue to human mycosis fungoides (MF). In human MF, neoplastic cells are phenotypically consistent with resident effector memory T cells, a population that remains for an extended period within tissue without circulating. Dogs with eCTCL often present with lesions in multiple locations, raising the question of whether the neoplasm is of the same T-cell subpopulation or not.&#13;
Objectives: To characterize the antigen receptor gene rearrangements of lymphocytes from skin and blood of dogs with eCTCL to determine if neoplastic clones are identical.&#13;
Animals. Fourteen dogs with eCTCL.&#13;
Materials and methods. Histological and immunohistochemical examination, and PCR for antigen receptor rearrangement (PARR) for T-cell receptor gamma (TRG) performed on multiple cutaneous biopsy samples and blood.&#13;
Results. All skin biopsies contained cluster of differentiation (CD)3-positive neoplastic lymphocytes. Within individual dogs, all skin biopsies revealed identical TRG clonality profiles, suggesting that the same neoplastic clone was present in all sites. In the blood, a matching clone was found in six of 14 dogs, a unique clone was observed in nine of 14 dogs, and no clone was detected in two of 14 dogs.&#13;
Conclusions. These findings show that canine eCTCL lesions in multiple locations harbour the same neoplastic clone, neoplastic lymphocytes do not remain fixed to the skin and instead can circulate via blood, differing clones can be identified in skin versus blood, and circulating neoplastic cells can be detected without lymphocytosis.</p>
   </trans-abstract>
   <kwd-group xml:lang="ru">
    <kwd>эпителиотропная кожная Т-клеточная лимфома</kwd>
    <kwd>собаки</kwd>
    <kwd>клональность опухоли</kwd>
    <kwd>перестройка гена антигенного рецептора лимфоцитов</kwd>
   </kwd-group>
   <kwd-group xml:lang="en">
    <kwd>epitheliotropic cutaneous T-cell lymphoma</kwd>
    <kwd>dogs</kwd>
    <kwd>tumor clonality</kwd>
    <kwd>antigen receptor gene rearrangements of lymphocytes</kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <p></p>
 </body>
 <back>
  <ref-list>
   <ref id="B1">
    <label>1.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Kempf W., Zimmermann A.K., Mitteldorf C., Cutaneous lymphomas - An update 2019., Hematol Oncol., 2019, No. 37(S1), pp. 43-47.</mixed-citation>
     <mixed-citation xml:lang="en">Kempf W., Zimmermann A.K., Mitteldorf C., Cutaneous lymphomas - An update 2019., Hematol Oncol., 2019, No. 37(S1), pp. 43-47.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B2">
    <label>2.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Campbell J.J., Clark R.A., Watanabe R., Kupper T.S., Sézary syndrome and mycosis fungoides arise from distinct T-cell subsets: A biologic rationale for their distinct clinical behaviors, Blood, 2010, No. 116(5), pp. 767-771.</mixed-citation>
     <mixed-citation xml:lang="en">Campbell J.J., Clark R.A., Watanabe R., Kupper T.S., Sézary syndrome and mycosis fungoides arise from distinct T-cell subsets: A biologic rationale for their distinct clinical behaviors, Blood, 2010, No. 116(5), pp. 767-771.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B3">
    <label>3.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Willemze R., Meijer C.J., Classification of Cutaneous T-Cell Lymphoma: From Alibert to WHO-EORTC. J Cutan Pathol., 2006, No. 33(S1), pp. 18-26.</mixed-citation>
     <mixed-citation xml:lang="en">Willemze R., Meijer C.J., Classification of Cutaneous T-Cell Lymphoma: From Alibert to WHO-EORTC. J Cutan Pathol., 2006, No. 33(S1), pp. 18-26.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B4">
    <label>4.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Willemze R., Cerroni L., Kempf W., Berti E., Facchetti F., Swerdlow S.H. et al., The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas, Blood 2019, No. 133(16), pp. 1703-1714.</mixed-citation>
     <mixed-citation xml:lang="en">Willemze R., Cerroni L., Kempf W., Berti E., Facchetti F., Swerdlow S.H. et al., The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas, Blood 2019, No. 133(16), pp. 1703-1714.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B5">
    <label>5.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Moore P.F., Affolter V.K., Graham P.S., Hirt B., Canine epitheliotropic cutaneous T-cell lymphoma: An investigation of T-cell receptor immunophenotype, lesion topography and molecular clonality, Vet Dermatol., 2009, No. 20(5-6), pp. 569-76.</mixed-citation>
     <mixed-citation xml:lang="en">Moore P.F., Affolter V.K., Graham P.S., Hirt B., Canine epitheliotropic cutaneous T-cell lymphoma: An investigation of T-cell receptor immunophenotype, lesion topography and molecular clonality, Vet Dermatol., 2009, No. 20(5-6), pp. 569-76.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B6">
    <label>6.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Chan C.M., Frimberger A.E., Moore A.S., Clinical outcome and prognosis of dogs with histopathological features consistent with epitheliotropic lymphoma: a retrospective study of 148 cases (2003-2015), Vet Dermatol., 2018, No. 29(2), pp. 154-e59.</mixed-citation>
     <mixed-citation xml:lang="en">Chan C.M., Frimberger A.E., Moore A.S., Clinical outcome and prognosis of dogs with histopathological features consistent with epitheliotropic lymphoma: a retrospective study of 148 cases (2003-2015), Vet Dermatol., 2018, No. 29(2), pp. 154-e59.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B7">
    <label>7.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Ewing T.S., Pieper J.B., Stern A.W., Prevalence of CD20 + cutaneous epitheliotropic T-cell lymphoma in dogs: a retrospective analysis of 24 cases (2011-2018) in the USA, Vet Dermatol., 2019, No. 30(1), pp. 51-e14.</mixed-citation>
     <mixed-citation xml:lang="en">Ewing T.S., Pieper J.B., Stern A.W., Prevalence of CD20 + cutaneous epitheliotropic T-cell lymphoma in dogs: a retrospective analysis of 24 cases (2011-2018) in the USA, Vet Dermatol., 2019, No. 30(1), pp. 51-e14.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B8">
    <label>8.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Moore P.F., Olivry T., Naydan D., Animal model canine cutaneous epitheliotropic lymphoma (mycosis fungoides) is a proliferative disorder of CD8+ T Cells, Am J Pathol., 1994, No. 144(2), pp. 421-429.</mixed-citation>
     <mixed-citation xml:lang="en">Moore P.F., Olivry T., Naydan D., Animal model canine cutaneous epitheliotropic lymphoma (mycosis fungoides) is a proliferative disorder of CD8+ T Cells, Am J Pathol., 1994, No. 144(2), pp. 421-429.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B9">
    <label>9.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Watanabe R., Gehad A., Yang C., Scott L.S., Teague J.E., Schlapbach C. et al., Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells, Sci. Transl Med., 2015, No. 7(279), pp. 279ra39.</mixed-citation>
     <mixed-citation xml:lang="en">Watanabe R., Gehad A., Yang C., Scott L.S., Teague J.E., Schlapbach C. et al., Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells, Sci. Transl Med., 2015, No. 7(279), pp. 279ra39.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B10">
    <label>10.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Clark R.A., Resident memory T cells in human health and disease, Sci Transl Med., 2015, No. 7(269), pp. 269rv1.</mixed-citation>
     <mixed-citation xml:lang="en">Clark R.A., Resident memory T cells in human health and disease, Sci Transl Med., 2015, No. 7(269), pp. 269rv1.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B11">
    <label>11.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Jubala C.M., Wojcieszyn J.W., Valli V.E.O., Getzy D.M., Fosmire S.P., Coffey D. et al. CD20 expression in normal canine B cells and in canine non-Hodgkin lymphoma, Vet Pathol., 2005, No. 42(4), pp. 468-76.</mixed-citation>
     <mixed-citation xml:lang="en">Jubala C.M., Wojcieszyn J.W., Valli V.E.O., Getzy D.M., Fosmire S.P., Coffey D. et al. CD20 expression in normal canine B cells and in canine non-Hodgkin lymphoma, Vet Pathol., 2005, No. 42(4), pp. 468-76.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B12">
    <label>12.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Valli V.E., Vernau W., de Lorimier L.P., Graham P.S., Moore P.F., Canine indolent nodular lymphoma, Vet Pathol., 2006, No. 43, pp. 241-56.</mixed-citation>
     <mixed-citation xml:lang="en">Valli V.E., Vernau W., de Lorimier L.P., Graham P.S., Moore P.F., Canine indolent nodular lymphoma, Vet Pathol., 2006, No. 43, pp. 241-56.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B13">
    <label>13.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Keller S.M., Moore P.F., A novel clonality assay for the assessment of canine T cell proliferations, Vet Immunol Immunopathol., 2012, No. 145(1-2), pp. 410-9.</mixed-citation>
     <mixed-citation xml:lang="en">Keller S.M., Moore P.F., A novel clonality assay for the assessment of canine T cell proliferations, Vet Immunol Immunopathol., 2012, No. 145(1-2), pp. 410-9.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B14">
    <label>14.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Keller S.M., Moore P.F., Rearrangement patterns of the canine TCRγ locus in a distinct group of T cell lymphomas, Vet Immunol Immunopathol., 2012, No. 145(1-2), pp. 350-61.</mixed-citation>
     <mixed-citation xml:lang="en">Keller S.M., Moore P.F., Rearrangement patterns of the canine TCRγ locus in a distinct group of T cell lymphomas, Vet Immunol Immunopathol., 2012, No. 145(1-2), pp. 350-61.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B15">
    <label>15.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Rütgen BC, Flickinger I, Wolfesberger B, Litschauer B, Fuchs-Baumgartinger A, Hammer SE et al. Cutaneous T-cell lymphoma - Sézary syndrome in a Boxer. Vet Clin Pathol 2016;45(1):172-8.</mixed-citation>
     <mixed-citation xml:lang="en">Rütgen BC, Flickinger I, Wolfesberger B, Litschauer B, Fuchs-Baumgartinger A, Hammer SE et al. Cutaneous T-cell lymphoma - Sézary syndrome in a Boxer. Vet Clin Pathol 2016;45(1):172-8.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B16">
    <label>16.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Fontaine J., Heimann M., Day M.J., Canine cutaneous epitheliotropic T-cell lymphoma: a review of 30 cases, Vet Dermatol, 2010, No. 21(3), pp. 267-75.</mixed-citation>
     <mixed-citation xml:lang="en">Fontaine J., Heimann M., Day M.J., Canine cutaneous epitheliotropic T-cell lymphoma: a review of 30 cases, Vet Dermatol, 2010, No. 21(3), pp. 267-75.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B17">
    <label>17.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Clark R.A., Human skin in the game, Sci Transl Med., 2013, No. 5(204), pp. 204ps13.</mixed-citation>
     <mixed-citation xml:lang="en">Clark R.A., Human skin in the game, Sci Transl Med., 2013, No. 5(204), pp. 204ps13.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B18">
    <label>18.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Klicznik M.M., Morawski P.A., Höllbacher B., Varkhande S.R., Motley S.J., Kuri-Cervantes L., Goodwin E. et al., Human CD4 + CD103 + cutaneous resident memory T cells are found in the circulation of healthy individuals, Sci Immunol., 2019, No. 4(37), eaav8995.</mixed-citation>
     <mixed-citation xml:lang="en">Klicznik M.M., Morawski P.A., Höllbacher B., Varkhande S.R., Motley S.J., Kuri-Cervantes L., Goodwin E. et al., Human CD4 + CD103 + cutaneous resident memory T cells are found in the circulation of healthy individuals, Sci Immunol., 2019, No. 4(37), eaav8995.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B19">
    <label>19.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Keller R.L., Avery A.C., Burnett R.C., Walton J.A., Olver C.S., Detection of neoplastic lymphocytes in peripheral blood of dogs with lymphoma by polymerase chain reaction for antigen receptor gene rearrangement, Vet Clin Pathol., 2004, No. 33(3), pp. 145-9.</mixed-citation>
     <mixed-citation xml:lang="en">Keller R.L., Avery A.C., Burnett R.C., Walton J.A., Olver C.S., Detection of neoplastic lymphocytes in peripheral blood of dogs with lymphoma by polymerase chain reaction for antigen receptor gene rearrangement, Vet Clin Pathol., 2004, No. 33(3), pp. 145-9.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B20">
    <label>20.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Yamazaki J., Baba K., Goto-Koshino Y., Setoguchi-Mukai A., Fujino Y., Ohno K. et al,. Quantitative assessment of minimal residual disease (MRD) in canine lymphoma by using realtime polymerase chain reaction, Vet Immunol Immunopathol., 2008, No. 126(3-4), pp. 321-31.</mixed-citation>
     <mixed-citation xml:lang="en">Yamazaki J., Baba K., Goto-Koshino Y., Setoguchi-Mukai A., Fujino Y., Ohno K. et al,. Quantitative assessment of minimal residual disease (MRD) in canine lymphoma by using realtime polymerase chain reaction, Vet Immunol Immunopathol., 2008, No. 126(3-4), pp. 321-31.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B21">
    <label>21.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Hiyoshi-Kanemoto S., Goto-Koshino Y., Fukushima K., Takahashi M., Kanemoto H., Uchida K. et al., Detection of circulating tumor cells using GeneScan analysis for antigen receptor gene rearrangements in canine lymphoma patients, J Vet Med Sci., 2016, No. 78(5), pp. 877-81.</mixed-citation>
     <mixed-citation xml:lang="en">Hiyoshi-Kanemoto S., Goto-Koshino Y., Fukushima K., Takahashi M., Kanemoto H., Uchida K. et al., Detection of circulating tumor cells using GeneScan analysis for antigen receptor gene rearrangements in canine lymphoma patients, J Vet Med Sci., 2016, No. 78(5), pp. 877-81.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B22">
    <label>22.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Lana S.E., Jackson T.L., Burnett R.C., Morley P.S., Avery A.C., Utility of polymerase chain reaction for analysis of antigen recept rearrangement in staging and predicting prognosis in dogs with lymphoma, J Vet Intern Med, 2006, No. 20(2), pp. 329-34.</mixed-citation>
     <mixed-citation xml:lang="en">Lana S.E., Jackson T.L., Burnett R.C., Morley P.S., Avery A.C., Utility of polymerase chain reaction for analysis of antigen recept rearrangement in staging and predicting prognosis in dogs with lymphoma, J Vet Intern Med, 2006, No. 20(2), pp. 329-34.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B23">
    <label>23.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Sato M., Yamazaki J., Goto-Koshino Y., Takahashi M., Fujino Y., Ohno K. et al., Increase in minimal residual disease in peripheral blood before clinical relapse in dogs with lymphoma that achieved complete remission after chemotherapy, J Vet Intern Med, 2011, No. 25(2), pp. 292-6.</mixed-citation>
     <mixed-citation xml:lang="en">Sato M., Yamazaki J., Goto-Koshino Y., Takahashi M., Fujino Y., Ohno K. et al., Increase in minimal residual disease in peripheral blood before clinical relapse in dogs with lymphoma that achieved complete remission after chemotherapy, J Vet Intern Med, 2011, No. 25(2), pp. 292-6.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B24">
    <label>24.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Scarisbrick J.J., Whittaker S., Evans A.V., Fraser-Andrews E.A., Child F.J., Dean A. et al., Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma, Blood, 2001, No. 97(3), pp. 624-30.</mixed-citation>
     <mixed-citation xml:lang="en">Scarisbrick J.J., Whittaker S., Evans A.V., Fraser-Andrews E.A., Child F.J., Dean A. et al., Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma, Blood, 2001, No. 97(3), pp. 624-30.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B25">
    <label>25.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Fraser-Andrews E.A., Woolford A.J., Russell-Jones R., Seed P.T., Whittaker S.J., Detection of a peripheral blood T cell clone is an independent prognostic marker in mycosis fungoides, J Invest Dermatol., 2000, No. 114(1), pp. 117-21.</mixed-citation>
     <mixed-citation xml:lang="en">Fraser-Andrews E.A., Woolford A.J., Russell-Jones R., Seed P.T., Whittaker S.J., Detection of a peripheral blood T cell clone is an independent prognostic marker in mycosis fungoides, J Invest Dermatol., 2000, No. 114(1), pp. 117-21.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B26">
    <label>26.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Sato M., Yamzaki J., Goto-Koshino Y., Takahashi M., Fujino Y., Ohno K. et al., The prognostic significance of minimal residual disease in the early phases of chemotherapy in dogs with highgrade B-cell lymphoma, Vet J., 2013, No. 195(3), pp. 319-24.</mixed-citation>
     <mixed-citation xml:lang="en">Sato M., Yamzaki J., Goto-Koshino Y., Takahashi M., Fujino Y., Ohno K. et al., The prognostic significance of minimal residual disease in the early phases of chemotherapy in dogs with highgrade B-cell lymphoma, Vet J., 2013, No. 195(3), pp. 319-24.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B27">
    <label>27.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Yamazaki J., Takahashi M., Setoguchi A., Fujino Y., Ohno K., Tsujimoto H., Monitoring of minimal residual disease (MRD) after multidrug chemotherapy and its correlation to outcome in dogs with lymphoma: a proof-of-concept pilot study, J Vet Intern Med., 2010, No. 24(4), pp. 897-903.</mixed-citation>
     <mixed-citation xml:lang="en">Yamazaki J., Takahashi M., Setoguchi A., Fujino Y., Ohno K., Tsujimoto H., Monitoring of minimal residual disease (MRD) after multidrug chemotherapy and its correlation to outcome in dogs with lymphoma: a proof-of-concept pilot study, J Vet Intern Med., 2010, No. 24(4), pp. 897-903.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B28">
    <label>28.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Cescon D.W., Bratman S.V., Chan S.M., Siu L.L., Circulating tumor DNA and liquid biopsy in oncology, Nat Cancer, 2020, No. 1(3), pp. 276-90.</mixed-citation>
     <mixed-citation xml:lang="en">Cescon D.W., Bratman S.V., Chan S.M., Siu L.L., Circulating tumor DNA and liquid biopsy in oncology, Nat Cancer, 2020, No. 1(3), pp. 276-90.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B29">
    <label>29.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Thilakaratne D.N., Mayer M.N., Macdonald V.S., Jackson M.L., Trask B.R., Kidney B.A., Article clonality and phenotyping of canine lymphomas before chemotherapy and during remission using polymerase chain reaction (PCR) on lymph node cytologic smears and peripheral blood, Can Vet J., 2010, No. 51(1), pp. 79-84.</mixed-citation>
     <mixed-citation xml:lang="en">Thilakaratne D.N., Mayer M.N., Macdonald V.S., Jackson M.L., Trask B.R., Kidney B.A., Article clonality and phenotyping of canine lymphomas before chemotherapy and during remission using polymerase chain reaction (PCR) on lymph node cytologic smears and peripheral blood, Can Vet J., 2010, No. 51(1), pp. 79-84.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B30">
    <label>30.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Keller S.M., Vernau W., Moore P.F., Clonality testing in veterinary medicine: a review with diagnostic guidelines, Vet Pathol., 2016, No. 53(4), pp. 711-25.</mixed-citation>
     <mixed-citation xml:lang="en">Keller S.M., Vernau W., Moore P.F., Clonality testing in veterinary medicine: a review with diagnostic guidelines, Vet Pathol., 2016, No. 53(4), pp. 711-25.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B31">
    <label>31.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Brady S.P., Magro C.M., Diaz-Cano S.J., Wolfe H.J., Analysis of clonality of atypical cutaneous lymphoid infiltrates associated with drug therapy by PCR/DGGE, Hum Pathol., 1999, No. 30(2), pp. 130-36.</mixed-citation>
     <mixed-citation xml:lang="en">Brady S.P., Magro C.M., Diaz-Cano S.J., Wolfe H.J., Analysis of clonality of atypical cutaneous lymphoid infiltrates associated with drug therapy by PCR/DGGE, Hum Pathol., 1999, No. 30(2), pp. 130-36.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B32">
    <label>32.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Magro C.M., Crowson A.N., Kovatich A.J., Burns F., Druginduced reversible lymphoid dyscrasia: a clonal lymphomatoid dermatitis of memory and activated T cells, Hum Pathol., 2003, No. 34(2), pp. 119-29.</mixed-citation>
     <mixed-citation xml:lang="en">Magro C.M., Crowson A.N., Kovatich A.J., Burns F., Druginduced reversible lymphoid dyscrasia: a clonal lymphomatoid dermatitis of memory and activated T cells, Hum Pathol., 2003, No. 34(2), pp. 119-29.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B33">
    <label>33.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Magro C.M., Daniels B.H., Crowson A.N., Drug induced pseudolymphoma. Semin Diagn Pathol., 2018, No. 35(4), pp. 247-59.</mixed-citation>
     <mixed-citation xml:lang="en">Magro C.M., Daniels B.H., Crowson A.N., Drug induced pseudolymphoma. Semin Diagn Pathol., 2018, No. 35(4), pp. 247-59.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B34">
    <label>34.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Lee P.L., Yee C., Savage P.A., Fong L., Brockstedt D., Weber J.S. et al., Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients, Nat Med., 1999, No. 5(6), pp. 677-85.</mixed-citation>
     <mixed-citation xml:lang="en">Lee P.L., Yee C., Savage P.A., Fong L., Brockstedt D., Weber J.S. et al., Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients, Nat Med., 1999, No. 5(6), pp. 677-85.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B35">
    <label>35.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Qurollo B.A., Davenport A.C., Sherbert B.M., Grindem C.B., Birkenheuer A.J., Breitschwerdt E.B., Infection with Panola Mountain Ehrlichia sp. in a dog with atypical lymphocytes and clonal T-cell expansion, J Vet Inter Med., 2013, No. 27(5), pp. 1251-5.</mixed-citation>
     <mixed-citation xml:lang="en">Qurollo B.A., Davenport A.C., Sherbert B.M., Grindem C.B., Birkenheuer A.J., Breitschwerdt E.B., Infection with Panola Mountain Ehrlichia sp. in a dog with atypical lymphocytes and clonal T-cell expansion, J Vet Inter Med., 2013, No. 27(5), pp. 1251-5.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B36">
    <label>36.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Melendez-Lazo A., Jasensky A.K., Jolly-Frahija I.T., Kehl A., Műller E., Mesa-Sánchez I., Clonality testing in the lymph nodes from dogs with lymphadenomegaly due to Leishmania infantum infection, PLoS One, 2019, No. 14(12), pp. e0226336.</mixed-citation>
     <mixed-citation xml:lang="en">Melendez-Lazo A., Jasensky A.K., Jolly-Frahija I.T., Kehl A., Műller E., Mesa-Sánchez I., Clonality testing in the lymph nodes from dogs with lymphadenomegaly due to Leishmania infantum infection, PLoS One, 2019, No. 14(12), pp. e0226336.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B37">
    <label>37.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Boon T., Coulie P.G., Van den Eynde B.J., van der Bruggen P., Human T cell responses against melanoma, Ann Rev Immunol., 2006, No. 24, pp. 175-208.</mixed-citation>
     <mixed-citation xml:lang="en">Boon T., Coulie P.G., Van den Eynde B.J., van der Bruggen P., Human T cell responses against melanoma, Ann Rev Immunol., 2006, No. 24, pp. 175-208.</mixed-citation>
    </citation-alternatives>
   </ref>
  </ref-list>
 </back>
</article>
